Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 19,474 | 43,484 | 38,837 | 49,604 | 38,230 |
| Cost of Goods | 3,098 | 15,258 | 12,802 | 14,822 | 4,090 |
| Gross Profit | 16,376 | 28,226 | 26,035 | 34,782 | 34,140 |
| Operating Expenses | 87,848 | 107,232 | 116,854 | 101,145 | 115,202 |
| Operating Income | -71,374 | -78,748 | -90,017 | -65,541 | -80,972 |
| Other Income | -4,765 | -10,293 | 9,263 | 4,958 | -2,250 |
| Pre-tax Income | -76,139 | -89,041 | -80,754 | -60,583 | -83,222 |
| Income Tax | -80 | -643 | 1 | -283 | 88 |
| Net Income Continuous | -76,059 | -88,398 | -80,755 | -60,300 | -83,310 |
| Net Income Discontinuous | -6,528 | N/A | N/A | N/A | -7,647 |
| Net Income | $-82,587 | $-80,751 | $-80,755 | $-60,300 | $-90,957 |
| EPS Basic Total Ops | -1.39 | -1.41 | -1.45 | -1.10 | -1.68 |
| EPS Basic Continuous Ops | -1.28 | -1.55 | -1.45 | -1.10 | -1.54 |
| EPS Basic Discontinuous Ops | -0.11 | N/A | N/A | N/A | -0.14 |
| EPS Diluted Total Ops | -1.39 | -1.41 | -1.45 | -1.10 | -1.68 |
| EPS Diluted Continuous Ops | -1.28 | -1.55 | -1.45 | -1.10 | -1.54 |
| EPS Diluted Discontinuous Ops | -0.11 | N/A | N/A | N/A | -0.14 |
| EPS Diluted Before Non-Recurring Items | -1.28 | -1.42 | -1.45 | -1.10 | -1.58 |
| EBITDA(a) | $-58,575 | $-68,475 | $-75,849 | $-49,204 | $-66,150 |